<DOC>
	<DOCNO>NCT01892930</DOCNO>
	<brief_summary>This pilot clinical trial study stereotactic body radiation therapy treat patient metastatic kidney cancer undergo surgery . Stereotactic radiation therapy may able send x-ray directly tumor cause less damage normal tissue .</brief_summary>
	<brief_title>Stereotactic Body Radiation Therapy Treating Patients With Metastatic Kidney Cancer Undergoing Surgery</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I. Assess impact stereotactic body radiation therapy ( SBRT ) immune system patient metastatic renal cell carcinoma ( RCC ) . SECONDARY OBJECTIVES : I. Assess change immune parameter prior radiation , post radiation post nephrectomy . TERTIARY OBJECTIVES : I. Assess surgical parameter partial radical nephrectomy post SBRT . OUTLINE : Patients undergo SBRT day 1 undergo partial radical nephrectomy day 29 . After completion study treatment , patient follow 30 day .</detailed_description>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>Have metastatic RCC primary tumor place Must surgical candidate deem fit surgeon Have measurable disease per Response Evaluation Criteria Solid Tumors ( RECIST ) 1.1 criterion present Patients childbearing potential must agree use adequate contraceptive method ( e.g. , hormonal barrier method birth control ; abstinence ) prior study entry duration study participation ; woman become pregnant suspect pregnant partner participate study , inform treat physician immediately Patient legal representative must understand investigational nature study sign Independent Ethics Committee/Institutional Review Board approve write informed consent form prior receive study related procedure Patients chemotherapy radiotherapy within 4 week ( 6 week nitrosoureas mitomycin C ) prior enter study recover adverse event due agent administer 4 week earlier Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement Radiation primary tumor prior enrollment study Pregnant nursing female patient Unwilling unable follow protocol requirement Any condition Investigator 's opinion deem patient unsuitable candidate receive treatment Received investigational agent within 30 day prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>